Unity Biotechnology, Inc.

About Unity Biotechnology, Inc.

Unity Biotechnology is a biopharmaceutical company focused on developing therapies that target cellular senescence to treat age-related diseases, particularly in ophthalmology and neurology. Its core programs include senolytic drugs like UBX1325 for eye diseases such as diabetic macular edema and age-related macular degeneration, aiming to eliminate senescent cells and reduce disease progression. The company leverages proprietary mechanisms to address fundamental aging processes, with a focus on clinical-stage development.